Accelerating Breakthrough Discoveries into Medicines
Led by experienced industry professionals
BioMotiv has a capable and connected management team, advisory board, and Board that oversee the development, funding, active management, and partnering of the portfolio of therapeutic products.
Our leadership and portfolio teams are well-versed in translational science, with deep pharmaceutical experience having supported the advancement of numerous programs into clinical development and into the marketplace.
Deep Business Networks
Through their careers, the company’s leadership team and advisory board members have developed broad relationships in the investment and pharmaceutical industries that are available to be accessed by BioMotiv companies.
Partnered with leading companies
The Harrington Project
to bridge the Valley of Death
BioMotiv has established a Philadelphia office as it continues to grow. The office is located in The Innovation Hub, a collaborative life sciences space managed by Militia Hill Ventures, next to 30th Street...
“Emerging drug discovery alliance models” discusses the current environment for early-stage drug discovery and development, highlights challenges to success, and suggests the need for allied partnerships in the drug development sphere using BioMotiv as one such model....
Our colleague, Kaushik Ghosal, will be joining the Association of University Technology Managers (AUTM) 2018 Annual Meeting as a panelist at the "Creative Models to De-Risk Early Stage BioMedical Technology Development" session on February 21. He will present...